Michelle L. Basil

Michelle L. Basil

Executive Vice President, General CounselatHaemonetics· In proxies 2021–2025

Pay in FY2023-12% from the year before

Michelle L. Basil was paid $3.0M in FY2023 (Apr), down 12%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Haemonetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. HaemoneticsPublic company · 5 yr
    • Executive Vice President, General Counsel2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?